Chronic kidney disease patients could be at similar levels of coronary risk to those who have previously had heart attac

Patients suffering from chronic kidney disease could be at as high a risk of coronary heart disease as patients who have previously had a heart attack, according to an article published Online First in the Lancet.

While it has long been established that patients with chronic kidney disease are at higher risk of heart attacks, the new study is the first large-scale, long-term study to examine whether kidney disease should be considered to be equivalent to having previously suffered a , in terms of the risk of future coronary events.

Lead researcher Dr Marcello Tonelli of the University of Alberta, said: "Our research suggests that there is a strong case for considering chronic kidney disease to be a coronary equivalent, meaning that people with chronic kidney disease are at a comparable risk of coronary events to those who have previously had a heart attack. Chronic kidney disease patients have substantially higher rates of death from heart disease after a heart attack than the general population, which emphasises the potential value of preventing coronary events through drug treatment and . In fact, the rate of death from heart disease among people with chronic kidney disease was similar to or higher than the rate of death among people with – in whom the value of preventive treatments is well known."

The study examined records from almost 1.3 million patients in Canada, comparing the incidence of heart attacks and death in patients with chronic kidney disease, diabetes, at least one previous heart attack, or a combination of these risk factors. The researchers found that people with chronic kidney disease, diabetes, or both, tended to experience a comparable risk of heart attack to those who had previously had a heart attack, suggesting that kidney disease could prove to be a useful prognostic marker for .

The findings are important because patients identified as having a coronary heart disease risk equivalent can receive targeted treatment – for example, with drugs such as statins, which reduce the risk of due to their effects of lowering "bad" fats (lipids) in the bloodstream. In the UK, almost 9% of the are thought to suffer from chronic kidney disease, which often – but not always – accompanies diabetes, already thought of as a coronary heart disease risk equivalent.

In an accompanying Comment, George Bakris of The University of Chicago, urges caution in the interpretation of the results, suggesting that although the study's large scale is an advantage, a lack of information about individuals' medication and other factors such as blood pressure means that the findings don't necessarily provide clear-cut support for the classification of chronic kidney disease as a coronary heart disease risk equivalent.

However, even if further analysis fails to support the classification of chronic kidney disease as a coronary risk equivalent, the work is still likely to have important implications for coronary disease prevention strategies. As Professor Bakris states: "Tonelli and colleagues offer new insight by comparing individuals with chronic kidney disease with those who have a history of heart attack, on a very large scale. Their findings emphasise the importance of primary prevention, particularly because patients with comprise a large proportion of patients who have heart attack."

More information: http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(12)60572-8

add to favorites email to friend print save as pdf

Related Stories

Heart drug 'safe for kidney patients'

Jun 13, 2011

(Medical Xpress) -- The full results of a trial show that people with chronic kidney disease can reduce their heart risk by taking a combination drug that lowers levels of ‘bad’ cholesterol.

Recommended for you

'Junk' blood tests may offer life-saving information

1 hour ago

Some 30 percent of all positive hospital blood culture samples are discarded every day because they're "contaminated"—they reflect the presence of skin germs instead of specific disease-causing bacteria.

Drug represents first potential treatment for common anemia

2 hours ago

An experimental drug designed to help regulate the blood's iron supply shows promise as a viable first treatment for anemia of inflammation, according to results from the first human study of the treatment published online today in Blood, the Journal of the American Society o ...

West Africans get creative with Ebola awareness

7 hours ago

A young man on camera names the person who's challenged him to dump the contents of a bucket over his head. But in a twist on the ice bucket challenge, this man is soon drenched in frothy, soapy water—part ...

User comments